William Wood

Assistant Professor of Medicine

University of North Carolina at Chapel Hill

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Wood is an Assistant Professor of Medicine at the University of North Carolina at Chapel Hill, USA. His research areas focus on patient outcomes in oncology, specifically exploring the perceptions of telehealth among cancer patients, the functional needs of those with metastatic breast cancer, and the impact of race and ethnicity on treatment outcomes. His recent publications include studies on genotype-guided therapies and decision-making experiences in older adults diagnosed with acute myeloid leukemia.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Deborah Mayer

Professor and Director of Cancer Survivorship

University of North Carolina at Chapel Hill

UNITED STATES

View details

Anita Turk

Assistant Professor of Clinical Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Wood

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Telephone Survey–Reported Perceptions of Telehealth Visits Among Black and Non-Black Patients Diagnosed With Cancer

Assessment of the functional and health-related needs of patients with metastatic breast cancer prior to initiation of cancer treatment

Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation

Experiences of treatment decision-making among older newly diagnosed adults with acute myeloid leukemia: a qualitative descriptive study

A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer

Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer

Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 study

Home Time among Older Adults with Acute Myeloid Leukemia Following Chemotherapy

Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: Feasibility and clinical relevance

Risk of adverse birth outcomes after adolescent and young adult cancer

Predicting Acute Care Events Among Patients Initiating Chemotherapy: A Practice-Based Validation and Adaptation of the PROACCT Model

Psychological processing among caregivers of allogeneic bone marrow transplant recipients: Qualitative findings from a longitudinal study

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)

Predictive Modeling for Adverse Events and Risk Stratification Programs for People Receiving Cancer Treatment

Survivorship Care of Older Adults With Cancer: Priority Areas for Clinical Practice, Training, Research, and Policy

Biometric Monitoring Technologies in Cancer: The Past, Present, and Future

Virtual Visits in Oncology: Enhancing Care Quality While Designing for Equity

Investigator Experiences Using Mobile Technologies in Clinical Research: Qualitative Descriptive Study

Collaborators (12)

JACOB NEWTON STEIN

Todd Schwartz

Natalie Grover

Barbara Fredrickson

Chad Wagoner

Eliza M. Park

Jennifer Elston Lafata

Sanghee Hong

Amy C. Cole

Erin Kent

Deborah Mayer

Anita Turk

Make your next move.